http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2
Mariz, F. C. (First author)DKFZ* ; Putzker, K.DKFZ* ; Sehr, P.DKFZ* ; Müller, M. (Last author)DKFZ*
2023
Frontiers Media
Lausanne
This record in other databases: 
Please use a persistent id in citations: doi:10.3389/fimmu.2023.1272018
Note: #EA:F035#LA:F035# / EMBL-DKFZ Chemical Biology Core Facility
Contributing Institute(s):
- Tumorvirus-spez. Vakzinierungsstrategie (F035)
- Gruppe Sehr EMBL (W040)
Research Program(s):
- 316 - Infektionen, Entzündung und Krebs (POF4-316) (POF4-316)
Appears in the scientific report
2023
Database coverage:
;

;

; Article Processing Charges ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection